Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period (T-NOX)

NCT04452188 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT04452188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04452188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period (T-NOX)
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Completed
Start date
January 18, 2021
Completion date
April 20, 2023
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary bypass, double outlet right ventricle with subaortic ventricular septal defect and pulmonary stenosis, double outlet right ventricle, subpulmonary vsd, hypoplastic left heart syndrome, pulmonary atresia with ventricular septal defect, tetralogy of fallot, total anomalous pulmonary venous return, transposition of the great arteries, truncus arteriosus